ALYSSA KIANI: Open Payments
NPI 1346863495 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,995 in 95 payments from 18 companies in 2025. Trend: 2023 $1,836 · 2024 $2,127 · 2025 $1,995
Food & beverage: $1,995
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $469 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $232 |
| Madrigal Pharmaceuticals | 7 | $174 |
| Aimmune Therapeutics, Inc. | 8 | $170 |
| Ardelyx, Inc. | 6 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $143 |
| Phathom Pharmaceuticals, Inc. | 8 | $93 |
| Celltrion USA Inc. | 3 | $87 |
| Janssen Biotech, Inc. | 4 | $87 |
| Intercept Pharmaceuticals, Inc. | 4 | $81 |
Products named: LINZESS, REZDIFFRA, ZENPEP, EOHILIA, IBSRELA, XIFAXAN, VOQUEZNA, VEGZELMA.
Industry payments across NC — which companies pay providers there.
